Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Physical Review. E|December 25, 2019
Design strategies for engineering soluto-inertial suspension interactionsAnirudha Banerjee, Douglas R Vogus, Todd M SquiresBioengineering & Translational Medicine|January 30, 2018
Schedule dependent synergy of gemcitabine and doxorubicin: Improvement of in vitro efficacy and lack of in vitro-in vivo correlationDouglas R Vogus, Anusha Pusuluri, Renwei Chen, et al.Lab on a Chip|February 10, 2015
Measuring concentration fields in microfluidic channels in situ with a Fabry-Perot interferometerDouglas R Vogus, Vincent Mansard, Michael V Rapp, et al.Journal of Colloid and Interface Science|February 14, 2012
Using bulk convection in a microtensiometer to approach kinetic-limited surfactant dynamics at fluid-fluid interfacesNicolas J Alvarez, Douglas R Vogus, Lynn M Walker, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|April 30, 2015
Synergistic antitumor activity of camptothecin-doxorubicin combinations and their conjugates with hyaluronic acidKathryn M Camacho, Sunny Kumar, Stefano Menegatti, et al.Advanced Healthcare Materials|September 22, 2020
Programmable Delivery of Synergistic Cancer Drug Combinations Using Bicompartmental NanoparticlesJason V Gregory, Douglas R Vogus, Alexandra Barajas, et al.ACS Nano|February 27, 2015
Elasticity of nanoparticles influences their blood circulation, phagocytosis, endocytosis, and targetingAaron C Anselmo, Mengwen Zhang, Sunny Kumar, et al.Angewandte Chemie (International Ed. in English)|December 12, 2018
Treating Tumors at Low Drug Doses Using an Aptamer-Peptide Synergistic Drug ConjugateAnusha Pusuluri, Vinu Krishnan, Valerie Lensch, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|April 2, 2016
DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapyKathryn M Camacho, Stefano Menegatti, Douglas R Vogus, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|August 22, 2017
A hyaluronic acid conjugate engineered to synergistically and sequentially deliver gemcitabine and doxorubicin to treat triple negative breast cancerDouglas R Vogus, Michael A Evans, Anusha Pusuluri, et al.Pageof 2